Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,672 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of fezolinetant on patient-reported quality-of-life outcomes: Data from a phase 3b study (DAYLIGHT) of the treatment of moderate to severe vasomotor symptoms associated with menopause in women considered unsuitable for hormone therapy.
Shapiro C M M, Wu X, Wang X, Miyazaki K, Morga A, Nappi RE, Stute P, Martins K, Schaudig K. Shapiro C M M, et al. Among authors: miyazaki k. Maturitas. 2024 Nov 26;193:108159. doi: 10.1016/j.maturitas.2024.108159. Online ahead of print. Maturitas. 2024. PMID: 39809112
Prognostic value of systemic immune-inflammation index in patients with small-cell lung cancer treated with immune checkpoint inhibitors.
Hamakawa Y, Hirahara A, Hayashi A, Ito K, Shinohara H, Shiba A, Higashi Y, Aga M, Miyazaki K, Taniguchi Y, Misumi Y, Agemi Y, Nakamura Y, Shimokawa T, Okamoto H. Hamakawa Y, et al. Among authors: miyazaki k. BMC Cancer. 2025 Jan 6;25(1):17. doi: 10.1186/s12885-025-13440-5. BMC Cancer. 2025. PMID: 39762819 Free PMC article.
Outcomes of Combined Atezolizumab Plus Chemotherapy in Non-small Cell Lung Cancer Patients in Clinical Practice.
Numata T, Nakamura R, Shiozawa T, Watanabe H, Okauchi S, Ogara G, Tamura T, Kikuchi N, Miyazaki K, Hayashi S, Yamashita T, Kurishima K, Inagaki M, Satoh H, Kaburagi T, Endo T, Hizawa N. Numata T, et al. Among authors: miyazaki k. Cancer Diagn Progn. 2025 Jan 3;5(1):105-114. doi: 10.21873/cdp.10418. eCollection 2025 Jan-Feb. Cancer Diagn Progn. 2025. PMID: 39758245 Free PMC article.
Gene-Silencing Therapeutic Approaches Targeting PI3K/Akt/mTOR Signaling in Degenerative Intervertebral Disk Cells: An In Vitro Comparative Study Between RNA Interference and CRISPR-Cas9.
Ryu M, Yurube T, Takeoka Y, Kanda Y, Tsujimoto T, Miyazaki K, Ohnishi H, Matsuo T, Kumagai N, Kuroshima K, Hiranaka Y, Kuroda R, Kakutani K. Ryu M, et al. Among authors: miyazaki k. Cells. 2024 Dec 9;13(23):2030. doi: 10.3390/cells13232030. Cells. 2024. PMID: 39682777 Free PMC article.
2,672 results